secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIBOTICS, INC. (AIBT)
CIK:        0001763329
Form:       8-K
Filed at:   2022-01-14T23:59:59+00:00
Accession:  0001096906-22-000130
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mycotopia Therapies appoints Benjamin Kaplan as CEO; $24k/mo consulting fee, 5% equity warrants
--------------------------------------------------------------------------------

- CEO appointment effective Jan 19, 2021; initial 36-month term with automatic 12-month renewal.
- Monthly consulting fee of $24,000; expense allowance of $7,000 per month; disability insurance provided.
- Equity compensation includes warrants for 5% of fully diluted shares as bonus milestones and a 5% stock grant on significant transactions.
- Termination without cause triggers a severance equal to three years of total compensation (fees, bonuses, equity grants, insurance).
- Agreement includes standard non-compete, non-solicitation, and confidentiality covenants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1763329/000109690622000130/0001096906-22-000130-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1763329/000109690622000130/tpia-20211117.htm
  HTML page:      https://secwatch.observer/filing/0001096906-22-000130

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer